Open Access

Bone mineral density in Canadian children with severe haemophilia A or B: a cross-sectional study


Cite

A study of Canadian children with severe haemophilia A and B shows they demonstrate difference in spine and total body bone mineral density from height-, age-, and weight-matched controls.
A study of Canadian children with severe haemophilia A and B shows they demonstrate difference in spine and total body bone mineral density from height-, age-, and weight-matched controls.

Figure 1

Bone mineral density height-age-weight-adjusted (HAW) score in Canadian children with severe haemophilia A or B: mean with 95% confidence interval
Bone mineral density height-age-weight-adjusted (HAW) score in Canadian children with severe haemophilia A or B: mean with 95% confidence interval

Figure 2

Spine HAW-score distribution and spine HAW plot
Spine HAW-score distribution and spine HAW plot

Figure 3

Hip HAW-score distribution and hip HAW plot
Hip HAW-score distribution and hip HAW plot

Figure 4

Whole body HAW-score distribution and whole body HAW plot
Whole body HAW-score distribution and whole body HAW plot

Figure 5

Physical activity levels
Physical activity levels

Participant characteristics

CLINICAL CHARACTERISTICS HAEMOPHILIA AMEAN +/− SD HAEMOPHILIA BMEAN +/− SD
N 33 5
Age (years, months) 10.2 +/− 4.8 9.5 +/− 3.8
Height (cm) 140.1 +/− 25.2 142.6 +/−23.5
Weight (kg) 37.9 +/− 21.2 39.3 +/− 19.1
BMI (kg/m2) 17.9 +/− 4.7 18.8 +/− 2.8
Lifetime joint bleeds 31.0 +/− 21.6 35.2 +/− 27.9
Hemophilia Joint Health Score 2.6 +/− 3.4 4.4 +/− 3.5
Whole body bone mineral content (kg) 1.2 +/− 0.7 1.25 +/− 0.7
Lean body mass (kg) 26.5 +/− 15.9 26.9 +/− 15.2
Fat mass (kg) 10.2 +/− 6.3 25.4 +/− 18.2
Prophylaxis starting age (years, months) 2.4 +/− 1.8 2.7 +/− 2.1
Prophylaxis frequency (days/week) 2.9 +/− 1.3 2.0 +/− 1
Adequate intake calcium (% of subjects) 75 100
Adequate intake vitamin D (% of subjects) 46 40
Adequate intake vitamin K (% of subjects) 28 40
Adequate intake protein (% of subjects) 91 100
Physical Activity Score (out of 10) 6.6 +/− 1.1 6.3 +/− 0.4

Univariate analysis hip HAW

PARAMETER LEVEL ESTIMATE (95% CI) PR>CHISQ
Regimen (vs. 1× week) 2× week −0.6333 (−2.2199,0.9532) 0.4340
Regimen (vs. 1× week) 3× week −0.0467 (−1.5201,1.4268) 0.9505
Joint score > 0 1 −0.3531 (−1.3340,0.6278) 0.4805
Physical activity: overall 0.3024 (−0.1655,0.7703) 0.2052
Calcium 1 0.7993 (−0.4363,2.0350) 0.2048
Vitamin D 1 1.0996 (0.1709,2.0282) 0.0203
Lifetime joint bleeds 0.0023 (−0.0169,0.0216) 0.8144

Multivariate analysis total body HAW

PARAMETER LEVEL ESTIMATE (95% CI) PR>CHISQ
Regimen (vs. 1× week) 2× week −0.0813 (−1.1006,0.9379) 0.8757
Regimen (vs. 1× week) 3× week 0.3864 (−0.6681,1.4410) 0.4726
Joint score > 0 1 0.6312 (0.0632,1.1992) 0.0294
Physical activity: overall −0.3563 (−0.8913,0.1786) 0.1917
Calcium 1 −0.4021 (−1.375,0.5707) 0.4179
Vitamin D 1 0.6189 (−0.0676,1.3054) 0.0772
Lifetime joint bleeds −0.0110 (−0.0261,0.0041) 0.1528

Univariate analysis spine HAW

PARAMETER LEVEL ESTIMATE (95% CI) PR>CHISQ
Regimen (vs. 1× week) 2× week −0.4000 (−1.6579,0.8579) 0.5331
Regimen (vs. 1× week) 3× week −0.1182 (−1.2795,1.0431) 0.8419
Joint score > 0 1 0.1095 (−0.6067,0.8257) 0.7644
Physical activity: overall 0.1256 (−0.2229,0.4741) 0.4801
Calcium 1 0.5588 (−0.3073,1.4249) 0.2060
Vitamin D 1 0.7800 (0.1023,1.4577) 0.0241
Lifetime joint bleeds 0.0095 (−0.0048,0.0238) 0.1916
eISSN:
2055-3390
Language:
English
Publication timeframe:
Volume Open
Journal Subjects:
Medicine, Basic Medical Science, other, Clinical Medicine, Pharmacy, Pharmacology